Industry Report on Early Phase Development – Integrated CPU And Bioanalytical Services Deliver Reduced Cycle Time And Cost Savings For Early Phase Trial Sponsors

October 6, 2021

In clinical trials where timeline and budget are critical concerns, sponsors need strategies to reduce time lag and increase efficiencies. A new industry report released by Worldwide Clinical Trials, “Integrated CPU and Bioanalytical Services Deliver Reduced Cycle Time and Cost Savings for Early Phase Trial Sponsors,” discusses the advantages sponsors receive when using our colocated clinical pharmacology unit (CPU) and bioanalytical (BioA) lab. In the report, we outline the benefits and suggest potential use cases where these benefits might best be realized.

Your form has been successfully submitted! Click the button below to access.
VIEW PDF